Novel Macrocyclic LRRK2 Inhibitors for Treating Parkinson's Disease

被引：1
|
作者：
Sabnis, Ram W. [1 ]
机构：
[1] Smith Gambrell & Russell LLP, Atlanta, GA 30309 USA
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2022年
关键词：
D O I：
10.1021/acsmedchemlett.1c00687
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] LRRK2 activation in idiopathic Parkinson's disease
    Di Maio, Roberto
    Hoffman, Eric K.
    Rocha, Emily M.
    Keeney, Matthew T.
    Sanders, Laurie H.
    De Miranda, Briana R.
    Zharikov, Alevtina
    Van Laar, Amber
    Stepan, Antonia F.
    Lanz, Thomas A.
    Kofler, Julia K.
    Burton, Edward A.
    Alessi, Dario R.
    Hastings, Teresa G.
    Greenamyre, J. Timothy
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (451)
  • [42] Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease
    Nichols, R. Jeremy
    Dzamko, Nicolas
    Hutti, Jessica E.
    Cantley, Lewis C.
    Deak, Maria
    Moran, Jennifer
    Bamborough, Paul
    Reith, Alastair D.
    Alessi, Dario R.
    BIOCHEMICAL JOURNAL, 2009, 424 : 47 - 60
  • [43] Using computer modeling to find new LRRK2 inhibitors for parkinson's disease
    Garcia, Maria C.
    Cuesta, Sebastian A.
    Mora, Jose R.
    Paz, Jose L.
    Marrero-Ponce, Yovani
    Alexis, Frank
    Marquez, Edgar A.
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [44] Catalyzing a Cure: Discovery and development of LRRK2 inhibitors for the treatment of Parkinson's disease
    Baidya, Anurag T. K.
    Deshwal, Sonam
    Das, Bhanuranjan
    Mathew, Alen T.
    Devi, Bharti
    Sandhir, Rajat
    Kumar, Rajnish
    BIOORGANIC CHEMISTRY, 2024, 143
  • [45] Structural Insights and Development of LRRK2 Inhibitors for Parkinson's Disease in the Last Decade
    Thakur, Gunjan
    Kumar, Vikas
    Lee, Keun Woo
    Won, Chungkil
    GENES, 2022, 13 (08)
  • [46] Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease Models
    Kramer, Thomas
    Lo Monte, Fabio
    Goering, Stefan
    Amombo, Ghislaine Marlyse Okala
    Schmidt, Boris
    ACS CHEMICAL NEUROSCIENCE, 2012, 3 (03): : 151 - 160
  • [47] Inhibitors of LRRK2 Kinase Activity To Probe the Treatment Option in Parkinson's Disease
    Rautio, Jarkko
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 9414 - 9415
  • [48] LRRK2 mutations in Parkinson disease
    Farrer, M
    Stone, J
    Mata, IF
    Lincoln, S
    Kachergus, J
    Hulihan, M
    Strain, KJ
    Maraganore, DM
    NEUROLOGY, 2005, 65 (05) : 738 - 740
  • [49] The structure of LRRK2 and the conformational changes that are associated with LRRK2 activation and Parkinson's disease pathogenesis
    Weng, Jui-Hung
    Auto, Philip
    Lu, Tsan-Wen
    Taylor, Susan
    FASEB JOURNAL, 2020, 34
  • [50] The Structure of LRRK2 and the Conformational Changes that are Associated with LRRK2 Activation and Parkinson's Disease Pathogenesis
    Weng, Jui-Hung
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 41A - 41A
12345